Certain prostate medications might help reduce the risk of Lewy body dementia, a specific type of dementia, a new study suggests. Photo by Adobe Stock/HealthDay News Prostate medications might help ...

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...

New therapies are needed to help prevent the development of this condition. Researchers from the University of Iowa report that males taking three commonly prescribed prostate medications may lower ...

Prostate medicines may decrease Lewy body dementia risk, a recent study says. Drugs terazosin, doxazosin, and alfuzosin relax the prostate and bladder muscles. Patients receiving these ...

Charity hails ‘momentous’ decision to give abiraterone to about 8,000 newly diagnosed men each year ...

Certain drugs commonly used to treat enlarged prostate may also decrease the risk for dementia with Lewy bodies (DLB), according to a new study. The researchers think that a specific side effect of ...

Drug Used for Enlarged Prostate Tied to High Glaucoma Risk The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study ...

NEW YORK (Reuters Health) - Men taking cholesterol-lowering medication may be less likely to get prostate cancer than those not on the drugs, suggests a new study. They are also less likely to wind up ...

Prostate medications might help reduce the risk of a specific type of dementia, a new study suggests. People were less likely to develop Lewy body dementia when taking drugs designed to treat urinary ...

The NHS will provide a life-extending prostate cancer drug to men in England, expanding access to a treatment proven to ...